OBJECTIVE A competitive effect with suppression of Th2 immune responses of the tranilast and roxithromycin combination is examined in an allergic rhinitis patient. PATIENT AND METHODS A 42-year-old female patient… Click to show full abstract
OBJECTIVE A competitive effect with suppression of Th2 immune responses of the tranilast and roxithromycin combination is examined in an allergic rhinitis patient. PATIENT AND METHODS A 42-year-old female patient with allergic rhinitis caused by cedar pollen, which is one of the most common allergies during the spring, exhibited facial erythema with itching, particularly on both cheeks, and rhinitis symptoms, such as nasal discharge, and 200 mg/day of tranilast (original) and 300 mg/day of roxithromycin were administered. RESULTS After 2 weeks, the patient's skin lesions were mostly eliminated, with the skin appearing almost normal; itching was nearly absent; and rhinitis symptoms disappeared. CONCLUSION This combination may be a promising new therapeutic strategy for allergic rhinitis.
Journal Title: Immunopharmacology and immunotoxicology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!